Validation of an Reverse phase high performance liquid chromatography Method for In Vitro Quantification and Degradation Analysis of Naphthol AS-E Phosphate in Bulk Drugs and Nanoparticles.

IF 1.7 4区 医学 Q4 BIOCHEMICAL RESEARCH METHODS
Kangkan Sarma, Md Habban Akther, Maha Alsunbul, Abdul-Hamid Emwas, Mariusz Jaremko
{"title":"Validation of an Reverse phase high performance liquid chromatography Method for <i>In Vitro</i> Quantification and Degradation Analysis of Naphthol AS-E Phosphate in Bulk Drugs and Nanoparticles.","authors":"Kangkan Sarma, Md Habban Akther, Maha Alsunbul, Abdul-Hamid Emwas, Mariusz Jaremko","doi":"10.1177/1540658X251377978","DOIUrl":null,"url":null,"abstract":"<p><p>\n <i>This study presents the first validated High-performance liquid chromatography (HPLC) technique for quantifying naphthol AS-E phosphate (NASEP) in bulk drugs and nanoparticle formulation. A C18 HPLC cartridge (250 × 4.6 mm, 5 µm particle size) served as the stationary phase for quantification. The mobile phase consisted of Milli-Q water with 0.1% trifluoroacetic acid (TFA) in pump A and acetonitrile with 0.1% TFA in pump B, with a flow rate ranging from 0.8 to 1.2 mL/min. A 3<sup>2</sup> factorial design was employed to evaluate the robustness of the proposed method, using mobile phase composition (X<sub>1</sub>), flow rate (X<sub>2</sub>), and column temperature (X<sub>3</sub>) as independent variables and peak area (R<sub>1</sub>), retention time (R<sub>2</sub>), and percent recovery (R<sub>3</sub>) as response variables. The calibration range curve (10-500 µg/mL) was best fitted by quadratic regression. The linearity was reported in the above-mentioned range. The accuracy was 99.952% ± 0.961% at the 75% level, 99.58% ± 1.483% at the 100% level, and 99.789% ± 1.936% at the 125% level. The coefficient of variation was below 2% for both intraday and interday measurements, and the limits of detection and quantification were 0.038 and 0.115 µg/mL, respectively. The NASEP solution was stable (99.04% ± 0.0251%) for 48 h at 8°C. The forced degradation study also revealed that the NASEP solution remained stable in an acidic environment for 48 h at 40°C but degraded at 80°C (<i>p</i> < 0.046) in a time-dependent manner. In contrast, it was unstable in an alkaline medium, independent of temperature, and degraded in the presence of strong oxidizing agents (<i>p</i> < 0.039). Furthermore, NASEP encapsulated in a Gly-Arg-Gly-Asp-Ser pentapeptide and low-molecular-weight heparin functionalized metal-organic framework exhibited sustained drug release at acidic pH 5.4. The proposed NASEP quantification method was validated and is suitable for routine analysis in pharmaceutical formulations.</i>\n </p>","PeriodicalId":8586,"journal":{"name":"Assay and drug development technologies","volume":" ","pages":""},"PeriodicalIF":1.7000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Assay and drug development technologies","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/1540658X251377978","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}
引用次数: 0

Abstract

This study presents the first validated High-performance liquid chromatography (HPLC) technique for quantifying naphthol AS-E phosphate (NASEP) in bulk drugs and nanoparticle formulation. A C18 HPLC cartridge (250 × 4.6 mm, 5 µm particle size) served as the stationary phase for quantification. The mobile phase consisted of Milli-Q water with 0.1% trifluoroacetic acid (TFA) in pump A and acetonitrile with 0.1% TFA in pump B, with a flow rate ranging from 0.8 to 1.2 mL/min. A 32 factorial design was employed to evaluate the robustness of the proposed method, using mobile phase composition (X1), flow rate (X2), and column temperature (X3) as independent variables and peak area (R1), retention time (R2), and percent recovery (R3) as response variables. The calibration range curve (10-500 µg/mL) was best fitted by quadratic regression. The linearity was reported in the above-mentioned range. The accuracy was 99.952% ± 0.961% at the 75% level, 99.58% ± 1.483% at the 100% level, and 99.789% ± 1.936% at the 125% level. The coefficient of variation was below 2% for both intraday and interday measurements, and the limits of detection and quantification were 0.038 and 0.115 µg/mL, respectively. The NASEP solution was stable (99.04% ± 0.0251%) for 48 h at 8°C. The forced degradation study also revealed that the NASEP solution remained stable in an acidic environment for 48 h at 40°C but degraded at 80°C (p < 0.046) in a time-dependent manner. In contrast, it was unstable in an alkaline medium, independent of temperature, and degraded in the presence of strong oxidizing agents (p < 0.039). Furthermore, NASEP encapsulated in a Gly-Arg-Gly-Asp-Ser pentapeptide and low-molecular-weight heparin functionalized metal-organic framework exhibited sustained drug release at acidic pH 5.4. The proposed NASEP quantification method was validated and is suitable for routine analysis in pharmaceutical formulations.

反相高效液相色谱法用于原料药和纳米颗粒中萘酚AS-E磷酸的体外定量和降解分析的验证
本研究首次验证了高效液相色谱(HPLC)技术用于定量原料药和纳米颗粒制剂中的萘酚AS-E磷酸(NASEP)。固定相为C18 HPLC (250 × 4.6 mm, 5µm粒径)。流动相为含0.1%三氟乙酸(TFA)的milliq水(A泵)和含0.1% TFA的乙腈(B泵),流速范围为0.8 ~ 1.2 mL/min。采用32因子设计,以流动相组成(X1)、流速(X2)和柱温(X3)为自变量,峰面积(R1)、保留时间(R2)和回收率(R3)为响应变量,评价方法的稳健性。二次回归拟合的校准范围曲线为10 ~ 500µg/mL。在上述范围内呈线性关系。准确度在75%水平下为99.952%±0.961%,在100%水平上为99.58%±1.483%,在125%水平上为99.789%±1.936%。日内、日间测定变异系数均小于2%,检出限和定量限分别为0.038和0.115µg/mL。NASEP溶液在8℃下稳定(99.04%±0.0251%)48 h。强制降解研究还表明,NASEP溶液在40°C的酸性环境中保持48 h的稳定,但在80°C时降解(p < 0.046),并且具有时间依赖性。相反,它在碱性介质中不稳定,不受温度的影响,在强氧化剂的存在下会降解(p < 0.039)。此外,包裹在Gly-Arg-Gly-Asp-Ser五肽和低分子量肝素功能化金属-有机框架中的NASEP在酸性pH 5.4下表现出持续的药物释放。所建立的NASEP定量方法经验证,适用于制剂的常规分析。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Assay and drug development technologies
Assay and drug development technologies 医学-生化研究方法
CiteScore
3.60
自引率
0.00%
发文量
33
审稿时长
>12 weeks
期刊介绍: ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application. ASSAY and Drug Development Technologies coverage includes: -Assay design, target development, and high-throughput technologies- Hit to Lead optimization and medicinal chemistry through preclinical candidate selection- Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis- Approaches to assays configured for gene families, inherited, and infectious diseases- Assays and strategies for adapting model organisms to drug discovery- The use of stem cells as models of disease- Translation of phenotypic outputs to target identification- Exploration and mechanistic studies of the technical basis for assay and screening artifacts
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信